Status:
COMPLETED
Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections
Lead Sponsor:
A. Vogel AG
Collaborating Sponsors:
Cantonal Hospital of St. Gallen
Labormedizinisches Zentrum Dr. Risch
Conditions:
Respiratory Tract Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This is a comparative, conceptual, randomized clinical study to investigate newly developed over basic Echinacea formulations for the treatment of acute symptoms of respiratory tract infections. 400 a...
Detailed Description
The monocentre trial compares two newly developed pharmaceutical forms of Echinacea (extract from Echinacea purpurea Herba and Radix; lozenges or spray) with two basic and authorised pharmaceutical fo...
Eligibility Criteria
Inclusion
- At least 18 years old
- Signed Informed Consent
Exclusion
- Younger than 18 years
- Participation in another clinical study in the past 30 days
- Permanent intake of antimicrobial, antiviral, immune suppressive substances
- Surgical intervention in the 3 months prior to inclusion or planned surgery during period of observation
- Known diabetes melitus
- Known and treated atopy or asthma bronchiale
- Cystic fibrosis, bronchopulmonale dysplasia, COPD
- Known diseases of the immune system, degenerative illnesses (e.g. auto-immune disorders like AIDS or leukemia, myeloma)
- Known metabolic or resorptive disorders
- Known chronic liver diseases (chronic hepatitis, liver cirrhosis)
- Known chronic kidney insufficiency
- Serious health issues (reduced health status, autoimmune illness, tumorous illness)
- Known allergy to plants of compositae family (camomille, dandelion) or to any substances of the investigational product
- At inclusion known pregnancy or planned pregnancy during period of investigation (required: active contraception for women of childbearing year)
Key Trial Info
Start Date :
November 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 7 2019
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT03812900
Start Date
November 27 2018
End Date
June 7 2019
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cantonal Hospital St. Gallen
Sankt Gallen, Switzerland